A Phase I/IIa, Double-Blind, Placebo-Controlled Study Validating the Safety, Pharmacokinetics and Pharmacodynamic Profile of Sarconeos in Paediatric Patients with Duchenne Myopathy (MYODA-PK)
Phase of Trial: Phase I/II
Latest Information Update: 31 Oct 2019
Price : $35 *
At a glance
- Drugs Sarconeos (Primary)
- Indications Duchenne muscular dystrophy
- Focus Pharmacokinetics; Proof of concept
- Acronyms MYODA-PK
- Sponsors Biophytis
- 31 Oct 2019 According to an Biophytis media release, the company expects to file IND with FDA in Q4 2019.
- 02 Oct 2019 According to an Biophytis media release, two posters highlighting the innovative MYODA clinical trial design will be presented at the 24th International Annual Congress of the World Muscle Society (WMS).
- 19 Sep 2019 According to a Biophytis media release, this trial is expected to start in 2020.